Concerned About Hallucinations or Delusions Related to Alzheimer’s Disease?
Participate in Alzheimer’s Disease Psychosis Clinical Trial and Help Advance Future Treatment Research
Alzheimer’s Disease Psychosis (ADP) is a condition that affects many individuals living with Alzheimer’s disease. In addition to memory loss and cognitive decline, some patients may experience hallucinations, delusions, and other psychotic symptoms that can significantly impact daily life and caregiver burden.
Currently, treatment options for Alzheimer’s Disease Psychosis remain limited. Researchers continue to investigate new approaches that may help address these symptoms while maintaining safety and tolerability in older adults.
To help advance the development of potential future treatment options, Revival Research Institute is conducting an Alzheimer’s Disease Psychosis Clinical Trial evaluating an investigational study medication for adults experiencing hallucinations and delusions associated with Alzheimer’s disease.
Who Can Participate?
You may be eligible for the Alzheimer’s Disease Psychosis Clinical Trial if you:
- Have completed the Double-Blind Treatment Period of an antecedent study
- Must have a dedicated care partner who can participate in study visits and assessments
- Able and willing to provide informed consent
Participation may include study-related medical care, investigational study medication, health assessments, safety monitoring, and ongoing follow-up at no cost. No insurance is required.
About the Alzheimer’s Disease Psychosis Clinical Trial
At Revival Research Institute, we are conducting a clinical trial evaluating the long-term safety, tolerability, and effectiveness of an investigational treatment for adults with hallucinations and delusions associated with Alzheimer’s Disease Psychosis.
Our studies are conducted under strict ethical and regulatory standards, helping advance research aimed at improving the future care of individuals living with Alzheimer’s Disease Psychosis.
If you qualify, you may have the opportunity to receive the investigational study medication and ongoing study-related care at no cost.
*All study-related procedures and investigational study medication are provided free of charge, and no insurance is required.
*Participation in this clinical trial is completely voluntary. You may withdraw from the study at any time. Additional study requirements will be discussed by the study team if you choose to participate.
Get Started
What to Expect?
If you meet the study requirements, you may be eligible to participate in a clinical trial evaluating an investigational treatment for Alzheimer’s Disease Psychosis.
After you complete the interest form above, a member of our research team will contact you to conduct a brief pre-screening to determine whether you meet the initial study requirements.
Following consent, you will attend a screening visit at one of our research locations. During this visit, the study team will review your medical history, evaluate eligibility requirements, perform health assessments, and discuss participation in detail.
A designated care partner will also participate in certain study assessments and visits throughout the study.
Our research team will guide you through every step of the process and answer any questions you may have before you decide to participate. By joining this study, you are helping advance research that may improve future treatment options for individuals living with Alzheimer’s Disease Psychosis.
Age
Condition
Location
The Importance of Alzheimer’s Disease Psychosis Clinical Trials
Alzheimer’s disease affects millions of people worldwide, and psychotic symptoms such as hallucinations and delusions may occur in approximately 40% of individuals during the course of the disease.
These symptoms are associated with increased caregiver burden, faster cognitive decline, reduced quality of life, and a greater likelihood of hospitalization or long-term care placement.
Despite the significant impact of Alzheimer’s Disease Psychosis, treatment options remain limited. Clinical research plays a critical role in evaluating potential therapies that may help address these symptoms while maintaining patient safety.
By participating in Alzheimer’s Disease Psychosis clinical trials at Revival Research Institute, you can contribute to research that may help improve care and treatment options for future generations.
Risk Factors for Alzheimer’s Disease Psychosis
- Diagnosis of Alzheimer’s disease
- Progression of cognitive impairment
- Advanced age
- History of behavioral or psychiatric symptoms
- Increased disease severity
Common Symptoms of Alzheimer’s Disease Psychosis
- Visual or auditory hallucinations
- False beliefs (delusions)
- Suspicion or paranoia
- Confusion regarding people or surroundings
- Behavioral changes
- Increased caregiver burden
Frequently Asked Questions
Got Questions About Alzheimer’s Disease Psychosis Clinical Trials?
Have a look at some of our most frequently asked questions regarding clinical trials and what they’re all about. If you can’t find the answer you’re looking for, call us at: +1 (248) 721-9539.
